Projects funded by the NCN
New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epilepsy and neuropathic pain.
2021/41/N/NZ7/01181
Keywords:
hybrid compounds multifuncional drugs epilepsy neuropathic pain anticonvulsant activity antinociceptive activity
Descriptors:
- NZ7_014:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 20 - announced on 2021-03-15
Amount awarded: 209 940 PLN
Project start date (Y-m-d): 2022-01-26
Project end date (Y-m-d): 2025-01-25
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.